New recommendations have been published regarding the use of clinical outcome assessments in the development of drugs for rare diseases. These guidelines aim to enhance the evaluation of treatment efficacy and patient experience in clinical trials.
recommendations for the use of clinical outcome assessments in rare disease drug development
Original title: “Recommendations for the use of clinical outcome assessments in rare disease drug development.”